Cargando…
Effect of Baihu and Guizhi decoction in acute gouty arthritis: study protocol for a randomized controlled trial
BACKGROUND: The prevalence rates of gout worldwide have increased annually. Acute gouty arthritis (AGA) accounts for a large proportion of gout patients and causes severe physical and mental pain in patients. Controlling the occurrence and development of gout inflammation is the first step in the tr...
Autores principales: | He, Yikun, Dai, Chaoran, Shen, Jiaying, Chen, Qianwen, Gao, Jiandong, Pan, Xin, Gan, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013133/ https://www.ncbi.nlm.nih.gov/pubmed/35428324 http://dx.doi.org/10.1186/s13063-022-06194-z |
Ejemplares similares
-
Observation of the curative effect of Guizhi-Shaoyao-Zhimu decoction combined with methotrexate in the treatment of early rheumatoid arthritis based on ultrasonic evaluation: study protocol of a randomized, double-blind, controlled clinical trial
por: Shen, Jiaying, et al.
Publicado: (2021) -
Modified Baihu decoction therapeutically remodels gut microbiota to inhibit acute gouty arthritis
por: Wang, Xianyang, et al.
Publicado: (2022) -
Baihu Jia Guizhi Decoction Improves Rheumatoid Arthritis Inflammation by Regulating Succinate/SUCNR1 Metabolic Signaling Pathway
por: Chen, Huan, et al.
Publicado: (2019) -
Metabolic profiling and pharmacokinetic studies of Baihu-Guizhi decoction in rats by UFLC-Q-TOF–MS/MS and UHPLC-Q-TRAP-MS/MS
por: He, Yan, et al.
Publicado: (2022) -
Disease-Modifying Anti-rheumatic Drug Prescription Baihu-Guizhi Decoction Attenuates Rheumatoid Arthritis via Suppressing Toll-Like Receptor 4-mediated NLRP3 Inflammasome Activation
por: Li, Weijie, et al.
Publicado: (2021)